A detailed history of Ameriprise Financial Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Ameriprise Financial Inc holds 4,290,896 shares of AZN stock, worth $271 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,290,896
Previous 4,886,103 12.18%
Holding current value
$271 Million
Previous $381 Million 12.26%
% of portfolio
0.09%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.67 - $87.62 $45.6 Million - $52.2 Million
-595,207 Reduced 12.18%
4,290,896 $334 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $2.36 Million - $2.85 Million
35,312 Added 0.73%
4,886,103 $381 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $24.8 Million - $28.3 Million
406,187 Added 9.14%
4,850,791 $329 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $12.5 Million - $14 Million
201,896 Added 4.76%
4,444,604 $299 Million
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $13 Million - $14.4 Million
201,104 Added 4.98%
4,242,708 $287 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $58.1 Million - $63 Million
831,470 Added 25.9%
4,041,604 $289 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $1.56 Million - $1.77 Million
-24,733 Reduced 0.76%
3,210,134 $223 Million
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $15.3 Million - $19.9 Million
-282,222 Reduced 8.02%
3,234,867 $219 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $8.93 Million - $22.9 Million
-168,418 Reduced 4.57%
3,517,089 $193 Million
Q2 2022

Aug 15, 2022

SELL
$59.26 - $71.14 $16.3 Million - $19.6 Million
-275,666 Reduced 6.96%
3,685,507 $243 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $12 Million - $14.4 Million
214,937 Added 5.74%
3,961,173 $263 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $54.6 Million - $64.6 Million
1,011,472 Added 36.99%
3,746,236 $218 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $139 Million - $153 Million
2,508,987 Added 1111.27%
2,734,764 $164 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $5.58 Million - $6.94 Million
-115,313 Reduced 33.81%
225,777 $13.5 Million
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $984,983 - $1.14 Million
-20,886 Reduced 5.77%
341,090 $17 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $4.04 Million - $4.83 Million
83,294 Added 29.89%
361,976 $18.1 Million
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $3.67 Million - $4.22 Million
-69,061 Reduced 19.86%
278,682 $15.3 Million
Q2 2020

Aug 14, 2020

SELL
$43.1 - $55.31 $969,319 - $1.24 Million
-22,490 Reduced 6.07%
347,743 $18.4 Million
Q1 2020

May 15, 2020

BUY
$37.79 - $51.33 $165,520 - $224,825
4,380 Added 1.2%
370,233 $16.5 Million
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $1.56 Million - $1.86 Million
36,805 Added 11.19%
365,853 $18.2 Million
Q3 2019

Nov 14, 2019

SELL
$40.12 - $45.47 $55,245 - $62,612
-1,377 Reduced 0.42%
329,048 $14.7 Million
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $4.11 Million - $4.59 Million
-110,142 Reduced 25.0%
330,425 $13.6 Million
Q1 2019

May 15, 2019

SELL
$35.49 - $43.02 $8.29 Million - $10.1 Million
-233,718 Reduced 34.66%
440,567 $17.8 Million
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $862,966 - $971,363
23,412 Added 3.6%
674,285 $25.6 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $60.3 Million - $68.9 Million
-1,735,824 Reduced 72.73%
650,873 $25.8 Million
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $21 Million - $22.5 Million
-607,129 Reduced 20.28%
2,386,697 $83.9 Million
Q1 2018

May 15, 2018

SELL
$32.97 - $36.63 $5.55 Million - $6.16 Million
-168,227 Reduced 5.32%
2,993,826 $105 Million
Q4 2017

Feb 12, 2018

BUY
$32.09 - $34.78 $4.34 Million - $4.7 Million
135,272 Added 4.47%
3,162,053 $110 Million
Q3 2017

Nov 07, 2017

BUY
$28.96 - $34.0 $87.7 Million - $103 Million
3,026,781
3,026,781 $103 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.